• A randomized phase II study evaluating different schedules of nab-Paclitaxel in metastatic breast cancer

  • Study Chair
    Alessandra Gennari, MD
    Novara, Italy 

    Guy Jerusalem MD, PhD
    Liège, Belgium

    Statistician
    Meredith Regan

    Trial Coordinators
    Meredith Kissel, Dorene Polizzi

    Data Managers
    Monica Greco

    Monitoring
    ETOP IBCSG Partners Foundation
    Coordinating Center, Bern, Switzerland
    Phone: +41 31 511 94 00
    Fax: +41 31 511 94 01
    Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

    IBCSG Data Management Center/Frontier Science Foundation
    4033 Maple Road
    Amherst, New York 14226 USA
    Phone: +1 716 834 0900
    Fax: +1 716 833 3990
    Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


    Date of Activation
    October 31, 2012 

    Final Accrual
    258 patients 

    Accrual Closure Date 
    August 7, 2015 

    Trial Completion Date
    March 16, 2023

ETOP IBCSG Partners Foundation
Effingerstrasse 33
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: contact@etop.ibcsg.org

Member Login